OneMedNet Corporation (ONMDW) 株式分析

企業概要

OneMedNet Corporation (ONMDW) operates as a healthcare software provider delivering digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. The company also offers iRWD, a platform designed to supply regulatory-grade imaging and clinical data specifically for the pharmaceutical and device manufacturing sectors. Although specific sector and industry classifications are not disclosed in the available data, the business model focuses on specialized technology infrastructure for the medical and pharma industries. The firm's scale is reflected in an annual revenue of $1.36 million and a market capitalization that is not currently available for calculation due to missing market cap data. The reported revenue figure indicates that the company functions within a niche market, while the absence of a defined market cap suggests significant volatility or delisting status common for micro-cap entities with limited trading liquidity.

財務健全性

The company reported a trailing twelve-month revenue of $1.36 million alongside a net income loss of $2,801,000 and an EBITDA loss of $9,602,000. The substantial gap between the positive revenue of $1.36 million and the negative net income of $2,801,000 reveals a cost structure where operating expenses and losses significantly outweigh total sales, indicating high burn rates or heavy investment in R&D that has not yet translated to profitability. Free cash flow stands at -$7,840,750, which indicates that the company is consuming cash reserves rather than generating internal funds, thereby limiting its financial flexibility and reliance on external financing. Three distinct margin metrics highlight the severity of these losses: the gross margin is -37.0%, the operating margin is -345.9%, and the profit margin is -206.1%. These negative percentages indicate that the cost of goods sold exceeds revenue, operating expenses are disproportionately high relative to sales, and the bottom line is deeply eroded by the overall business operations. On the balance sheet, the company holds $585,000 in cash against $974,000 in debt, while the debt-to-equity ratio is not available for analysis. The cash position is insufficient to fully cover total debt, suggesting a leveraged balance sheet where liquidity is tight. The current ratio is 0.43, a figure well below 1.0, which indicates that the company possesses significantly fewer current assets than current liabilities, signaling potential short-term liquidity challenges. Return on Equity is not available, but the Return on Assets is -205.6%, a metric that reveals the company is generating negative returns on its asset base, indicating management has not yet achieved effective capital utilization.

バリュエーション評価

The trailing P/E ratio and forward P/E ratio are both not available due to the company's negative earnings, meaning traditional earnings-based valuation multiples cannot be calculated or compared. The price-to-book ratio is reported at -1.21, a negative figure that indicates the market value of the company is below its book value, often seen in distressed or unprofitable firms where the market does not assign a premium to its assets. The price-to-sales ratio and EV/EBITDA are also not available, preventing the use of revenue or enterprise value-based metrics to assess valuation relative to peers. Regarding trading range, the 52-week high is $0.07 and the 52-week low is $0.07, meaning the stock is currently trading at 0% relative to this range as the high and low are identical. This identical high and low suggests the stock has been range-bound or inactive at a specific price point over the last year. The beta value is 1.17, which implies that the stock's price volatility is 17% higher than the broader market, indicating higher sensitivity to market swings compared to large-cap equities.

Growth & Income

Revenue growth year-over-year is reported at an extraordinary 3326.9%, while earnings growth year-over-year is not available due to the company's negative earnings position. The revenue growth figure suggests a massive expansion in sales volume or a significant change in the calculation basis, yet without available earnings growth data, it is impossible to determine if profitability is improving at a faster or slower pace than revenue. As the company does not pay dividends, indicated by a non-available dividend yield and payout ratio, it does not distribute cash to shareholders. Instead, the firm retains all earnings, if any exist, or relies on external capital to fund operations and growth initiatives rather than returning capital via dividends. The overall growth and income profile is characterized by explosive top-line revenue expansion coupled with significant losses and an absence of dividend income, reflecting a high-risk, high-volatility investment characteristic of pre-profitability technology firms.